Route of administration

Route of administration is the path by which a substance crosses from outside the body into systemic circulation. Different routes use different tissues — the gastrointestinal lining, the lungs, mucous membranes, skin, or blood vessels directly — each with its own permeability, surface area, and proximity to the bloodstream.

In clinical settings the term is often abbreviated ROA. Everyday language tends to name the action instead: swallowing, smoking, snorting, injecting. Both vocabularies describe the same underlying pharmacokinetic variable: where absorption begins, and how quickly the substance reaches its site of action.

Onset & absorption

The route determines how quickly a substance enters the bloodstream, how steeply plasma concentration rises, and whether the substance passes through the liver before reaching circulation.

Oral ingestion routes the substance through the gastrointestinal tract and then directly to the liver, where a portion may be metabolised before it ever reaches the brain — a process called first-pass metabolism. This flattens and delays the onset curve: effects rise gradually, peak later, and often persist longer relative to routes that bypass the liver.

Routes that bypass first-pass metabolism — inhalation, intravenous injection, and sublingual absorption among them — deliver substance to systemic circulation more directly. The rise is steeper and the peak concentration higher for the same administered amount. Effects arrive sooner and tend to return to baseline faster.

Harm reduction

Every route carries its own category of physical risk, independent of the pharmacology of any particular substance.

Inhalation and smoking place repeated thermal and chemical stress on respiratory tissue. Insufflation stresses the nasal mucosa and, with sustained use, the septum. Injection carries vascular injury risk and — when equipment is shared or technique is non-sterile — infection risk that extends to bloodborne pathogens. Rectal and buccal routes can irritate mucous membranes over time.

Routes that bypass first-pass metabolism narrow the margin between effect and overdose. The same administered amount may produce a substantially higher peak concentration by one of these routes than by oral ingestion, compressing the window for error. This is a property of the route, not of any particular substance.

What varies by substance

The route establishes the pharmacokinetic framework; the substance fills in the values. How efficiently a compound survives first-pass metabolism, how readily it crosses a given membrane, and what total amount ultimately reaches circulation are all substance-specific. One compound may absorb well through a mucous membrane while another is essentially inactive by the same path.

Patterns that hold for one compound should not be assumed to transfer to chemically similar ones. The practical guidance — whether a given route is effective for a substance, and how risks scale — belongs on the substance record, where it can be tied to its source.